Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 26Terminated 7Unknown 3Recruiting 2Withdrawn 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2NET 1Endocrine 1

Conditions

Pancreatitis 1Pancreatic Intraductal Neoplasms 1Neuroendocrine Tumors 1Gastro-enteropancreatic neuroendocrine tumor 1Fistula 1Duodenal Neoplasms 1

Interventions

Specimen Handling 336Magnetic Resonance Spectroscopy 333Radiotherapy 315Cyclophosphamide 295pembrolizumab 282Cisplatin 266Carboplatin 245Drug Therapy 237Blood Specimen Collection 233Biopsy 206Bevacizumab 187Gemcitabine 177venetoclax 172Radiosurgery 169Capecitabine 165Oxaliplatin 163fludarabine 160Nivolumab 156Paclitaxel 155Standard of Care 137Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 127Fluorouracil 125Docetaxel 113tislelizumab 110Rituximab 110Cytarabine 104atezolizumab 101Azacitidine 101

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × Octreotide × Clear all
NCT07262957 2025-12-22

PANENCA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 4 Recruiting
400 enrolled
Gastrointestinal

Pancreatic Intraductal Neoplasms, Duodenal Neoplasms, Fistula, Pancreatitis

NCT05701241 2024-06-14

SAUNA

University Hospital, Antwerp

Phase 4 Recruiting
270 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡